| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Director
1 company
Mauro Ferrari is Director at ARWR. Mauro Ferrari's net worth is not public. Form 4 filings only show shares in the companies where this person is an insider; those holdings are worth an estimated $4.1M at current prices.
Our model assigns Mauro Ferrari a strong insider score of 71/100, based on 4 past trades. Over a 12-month horizon, both of those trades were profitable, with an average 12-month return of +46.9%.
The ARWR filings lean toward selling, a net 50,583 shares.
Mauro Ferrari has 18 Form 4 filings on record from June 2016 to December 2025, all as Director at Arrowhead Pharmaceuticals (ARWR), 2016–2025.
The 20 reported transactions were 12 stock awards, 7 open-market sales and 1 option or other derivative award.
Counted by filing, the open-market trades come to no purchases and 6 sales worth about $2.3M.
The largest open-market sale was 7,530 shares of ARWR at an average $70.00 on December 26, 2025, about $527K.
2 of the 3 sales since April 2023 were made under a Rule 10b5-1 trading plan; the other was not.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 26, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell10b5-1 | 7,530 | $70.00 | $527,100.00 | -9.8% | -13.4% | - | |
| Nov 28, 2025 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 8,750 | $56.39 | $493,412.50 | -11.3% | +20.2% | - | |
| Jan 11, 2024 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell10b5-1 | 3,147 | $38.06 | $119,786.60 | -4.9% | -32.3% | -50.7% | |
| Dec 28, 2021 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 3,400 | $66.82 | $227,188.00 | -8.5% | -32.2% | -43.1% | |
| Oct 9, 2020 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 10,000 | $48.00 | $480,000.00 | -24.4% | - | - | |
| Jun 26, 2019 | ARWR Arrowhead Pharmaceuticals, Inc. | Director | Sell | 17,756 | $27.61 | $490,243.16 | -90.3% | - | - |